These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10592709)

  • 21. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP; Fan SR; Bai FY; Li J; Liao QP
    Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
    Hacioglu M; Guzel CB; Savage PB; Tan ASB
    Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Yeast species identification in vulvovaginal candidiasis: susceptibility to nystatin].
    Lisiak M; Kłyszejko C; Marcinkowski Z; Gwieździński Z
    Ginekol Pol; 2000 Sep; 71(9):959-63. PubMed ID: 11082956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on classification and treatment of vulvovaginal candidiasis].
    Fan SR; Liu XP; Li JW; Xu AP; Liu M
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):532-5. PubMed ID: 16202291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
    Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural changes of Candida albicans under influence of cyclosporin A.
    Krajewska-Kułak E; Niczyporuk W; Szynaka B
    Rocz Akad Med Bialymst; 1997; 42 Suppl 2():208-11. PubMed ID: 9646704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans.
    Boros-Majewska J; Turczyk Ł; Wei X; Milewski S; Williams DW
    J Appl Microbiol; 2015 Jul; 119(1):177-87. PubMed ID: 25845720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
    Martins HP; da Silva MC; Paiva LC; Svidzinski TI; Consolaro ME
    Acta Derm Venereol; 2012 Jan; 92(1):78-82. PubMed ID: 21918792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal activity of propolis extract against yeasts isolated from vaginal exudates.
    Dalben-Dota KF; Faria MG; Bruschi ML; Pelloso SM; Lopes-Consolaro ME; Svidzinski TI
    J Altern Complement Med; 2010 Mar; 16(3):285-90. PubMed ID: 20192913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens.
    El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
    Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
    Ng SM; Yap YY; Cheong JW; Ng FM; Lau QY; Barkham T; Teo JW; Hill J; Chia CS
    J Pept Sci; 2017 Mar; 23(3):215-221. PubMed ID: 28105725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the effectiveness of nystatin and kanesten in the treatment of vulvovaginal candidiasis].
    Kanadys W; Walkiewicz W; Drela M
    Wiad Lek; 1981 Apr; 34(8):663-5. PubMed ID: 7029920
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.
    Cross EW; Park S; Perlin DS
    Microb Drug Resist; 2000; 6(2):155-61. PubMed ID: 10990271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
    Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT
    Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.